The U.S. Food and Drug Administration (FDA) database lists an Abbreviated New Drug Application (ANDA) with the number ANDA086210 submitted by Watson Labs. The application pertains to a potassium chloride product intended for injection.
Key details of the product include:
- Brand name: Potassium Chloride
- Route of administration: Injection
- Dosage form: Injectable
- Product number: 001
- Reference drug status: No
- Marketing status: Discontinued
- Active ingredient: Potassium Chloride, strength 3 mEq/mL
- Reference standard: No
No additional information about the product’s approval status or market availability is provided beyond its discontinued marketing status.
Actualizaciones regulatorias9 sept 2026•3 min de lectura
FDA Announces Discontinuation of Watson Labs Potassium Chloride Injection (ANDA 086210)
The FDA records show that Watson Labs' potassium chloride injectable (3 mEq/mL) under ANDA 086210 is listed with a discontinued marketing status.
Recopilado por el equipo de Pharmacountry · Fuente: FDA.gov
Temas:
Calificaciones
(0)
(0)
(0)
(0)
(0)
Deja tu valoración